Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q2 2022 vs. Q1 2022
How the institutions holding Fortress Biotech, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 79 | 2 | 66 | −11 |
| Shares | 35.6M | 52.1K | 30.8M | −4.71M (−13.3%) |
| Value | $48.4M | $70.0K | $25.9M | −$22.5M (−46.4%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Fortress Biotech, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oasis Management Co Ltd. | 985,222 | $827.0K | 0.15% |
| Ergoteles LLC | 344,300 | $289.0K | 0.01% |
| Qube Research & Technologies Ltd | 64,626 | $54.0K | 0.00% |
| Sepio Capital, LP | 63,500 | $53.0K | 0.01% |
| LMR Partners LLP | 34,897 | $29.0K | 0.00% |
| RBF Capital, LLC | 30,000 | $25.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 28,370 | $24.0K | 0.00% |
| Engineers Gate Manager LP | 19,472 | $16.0K | 0.00% |
| Balyasny Asset Management LLC | 15,147 | $13.0K | 0.00% |
| Virtu Financial LLC | 13,560 | $11.0K | 0.00% |
| Commonwealth Equity Services, LLC | 11,658 | $9.00K | 0.00% |
| Urban Wealth Management, LLC | 7,635 | $6.00K | 0.02% |
| Essex Investment Management Co LLC | 5,700 | $5.00K | 0.00% |
| Group One Trading, L.P. | 2,000 | $2.00K | 0.00% |
| City State Bank | 127 | $0 | 0.00% |
Sold out (26)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 39,985 | $54.0K |
| Amalgamated Financial Corp. | 12,118 | $16.0K |